Skip to main content
. 2008 Oct 10;295(6):H2308–H2314. doi: 10.1152/ajpheart.00565.2008

Fig. 2.

Fig. 2.

Intracoronary infusion of adult MSCs (aMSCs) provided significantly better cardioprotection compared with neonatal MSCs (nMSCs). This was seen in end-diastolic pressure (EDP; A), cardiac contractility (+dP/dt; B), and rate of myocardial relaxation (−dP/dt; C) at end reperfusion. These data allowed for the important appreciation that an age threshold may exist as to when stem cells can provide beneficial tissue protection (n = 5 animals/group).